Insmed Incorporated
-
Ticker
INSM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Bridgewater, New Jersey
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-infective directly to the site of serious lung infections.
Insmed Incorporated
Most Recent Responsibility Report
MOST RECENT
2023 Responsibility Report
Report Locked. Insmed Incorporated has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Insmed Incorporated Sustainability Report, Insmed Incorporated Corporate Social Responsibility Report, Insmed Incorporated CSR Report, Insmed Incorporated Corporate Responsibility, Insmed Incorporated CR Report, Insmed Incorporated Citizenship Report, Insmed Incorporated ESG Report, and Insmed Incorporated Environmental Report online.